Trials / NCT07548944
Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual Performance
Recruiting now Observational Natural history / observational
- Sponsor
- Okuvision GmbH
- Treatment
- Transcorneal Electrical Stimulation using the OkuStim System
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa (RP), Usher Syndrome, Cone Rod Dystrophy
- Ages
- 18 Years to no upper limit
- Enrollment
- 30 participants
- Started
- 2026-04-20
- Main results expected
- 2027-03
- Results posted
- Not yet
- Record last updated
- 2026-05-01
What the study is testing
Retinitis pigmentosa and similar degenerative diseases of the retina lead to progressive loss of vision. TES therapy with the CE-marked OkuStim® System is a treatment approved in the EU for slowing the progression of the disease. Patients increasingly report short-term subjective improvements in vision, which have not yet been systematically investigated. This exploratory study is conducted to determine whether these subjective short-term effects can be measured, and therefore also be quantified, by objective tests.
Where it runs
Germany (1)
- Augenzentrum Frankfurt Prof. Koch GmbH, Frankfurt am Main (recruiting now)